Patents by Inventor John Keily

John Keily has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Lubricant Compositions Containing High C9 Disubstituted Diphenylamine Antioxidant Content and Low Mono- and Tri-substituted Diphenylamine Antioxidant Content
    Publication number: 20260109910
    Abstract: This disclosure relates to the use of di(alkyl substituted phenyl)amine antioxidants as additives in lubricant compositions having good oxidation properties in engine crankcase applications, especially in compression ignited engine and or spark ignited engine applications, where the antioxidant comprises from 0 to 15 mass % of mono-C9-alkyl substituted diphenyl amine and tri-C9-alkyl substituted diphenyl amine, and 85 to 100 mass % di-C9-alkyl substituted phenyl amines based upon the weight of the mono-, di- and tri-C9-alkyl substituted phenyl amines.
    Type: Application
    Filed: April 23, 2025
    Publication date: April 23, 2026
    Inventors: John Keily, Oliver J. Delamore, Paul Wilson, Ronak Shah, Stephen Arrowsmith, Marcus Popowicz
  • FUSED-RING POLYCYCLIC AMINE FUNCTIONALIZED OLEFINIC POLYMERS FOR LUBRICATING OIL COMPOSITIONS
    Publication number: 20250188379
    Abstract: This disclosure relates to functionalized olefinic polymers comprising an olefinic polymer bound to at least one fused-ring polycyclic amine for each polymer molecule, wherein the fused-ring polycyclic amine comprises at least one secondary amine and at least one other heteroatom therein and further comprises at least one primary amine directly pendant thereto, wherein the at least one fused-ring polycyclic amine is bound to the olefinic polymer through the at least the one primary amine.
    Type: Application
    Filed: November 18, 2024
    Publication date: June 12, 2025
    Applicant: INFINEUM INTERNATIONAL LIMITED
    Inventors: EVAN HAIDASZ, JOHN KEILY, MARK P. DRIVER
  • Lubricant Compositions Containing High C9 Disubstituted Diphenylamine Antioxidant Content
    Publication number: 20250136889
    Abstract: This disclosure relates to the use of di(alkyl substituted phenyl)amine antioxidants as additives in lubricant compositions having good oxidation properties in engine crankcase applications, especially in compression ignited engine and or spark ignited engine applications, where the antioxidant comprises from 0 to 10 mass % mono-C9-alkyl substituted diphenyl amine, and 90 to 100 mass % di-C9-alkyl substituted phenyl amines based upon the weight of the mono- and di-C9-alkyl substituted phenyl amines, preferably where tri-C9-alkyl substituted phenyl amines are minimized and ortho substituted di-C9-alkyl substituted phenyl amines are minimized.
    Type: Application
    Filed: October 23, 2024
    Publication date: May 1, 2025
    Applicant: INFINEUM INTERNATIONAL LIMITED
    Inventors: John KEILY, Oliver J. DELAMORE, Paul WILSON, Ronak M. SHAH, Stephen ARROWSMITH, Marcus POPOWICZ
  • Aryl Urea Derivatives for Treating Obesity
    Publication number: 20120214808
    Abstract: A method of treating a condition associated with the CB-1 receptor, in particular obesity, by administering an effective amount of an aryl urea CB-1 receptor modulating compound to a subject in need of such treatment.
    Type: Application
    Filed: February 17, 2012
    Publication date: August 23, 2012
    Applicant: Prosidion Limited
    Inventors: Jason Bloxham, Matthew Colin Thor Fyfe, James Horswill, Revathy Perpetua Jeevaratnam, John Keily, Martin James Procter, Karen Lesley Schofield, Salam Shaaban, Simon Andrew Swain, Philippe Wong-Kai-In
  • GPCR Agonists
    Publication number: 20120172358
    Abstract: Compounds of formula (I): or pharmaceutically acceptable salts thereof, are GPCR agonists and are useful as for the treatment of obesity and diabetes.
    Type: Application
    Filed: February 14, 2012
    Publication date: July 5, 2012
    Applicant: Prosidion Limited
    Inventors: Stuart Edward Bradley, Matthew Colin Thor Fyfe, Lisa Sarah Bertram, William Gattrell, Revathy Perpetua Jeevaratnam, John Keily, Martin James Procter, Chrystelle Marie Rasamison, Philip John Rushworth, Colin Peter Sambrook-Smith, David French Stonehouse, Simon Andrew Swain, Geoffrey Martyn Williams
  • PIPERIDINYL GPCR AGONISTS
    Publication number: 20110269734
    Abstract: Compounds of formula (I):or pharmaceutically acceptable salts thereof, are GPCR agonists and are useful as for the treatment of diabetes and obesity.
    Type: Application
    Filed: July 10, 2009
    Publication date: November 3, 2011
    Applicant: Prosidion Limited
    Inventors: Lisa Sarah Bertram, Matthew Colin Thor Fyfe, Revathy Perpetua Jeevaratnam, John Keily, Thomas Martin Krulle, Chrystelle Marie Rasamison, Colin Peter Sambrook-Smith, Simon Andrew Swain
  • Piperidine GPCR Agonists
    Publication number: 20110230507
    Abstract: Compounds of formula (I): or pharmaceutically acceptable salts thereof, are GPCR agonists and are useful as for the treatment of diabetes and obesity.
    Type: Application
    Filed: July 10, 2009
    Publication date: September 22, 2011
    Applicant: Prosidion Limited
    Inventors: Lisa Sarah Bertram, Matthew Colin Thor Fyfe, Revathy Perpetua Jeevaratnam, John Keily
  • Heterocyclic GPCR Agonists
    Publication number: 20110212939
    Abstract: Compounds of formula (I) or pharmaceutically acceptable salts thereof, are GPCR (GPR119) agonists and are useful as for the treatment of diabetes and obesity.
    Type: Application
    Filed: July 10, 2009
    Publication date: September 1, 2011
    Applicant: Prosidion Limited
    Inventors: Lisa Sarah Bertram, Philip Graham Clarke, Graham John Dawson, Peter Timothy Fry, Matthew Colin Thor Fyfe, William Gattrell, Revathy Perpetua Jeevaratnam, John Keily, Thomas Martin Krulle, Martin James Procter, Chrystelle Marie Rasamison, Colin Peter Sambrook-Smith, Simon Andrew Swain
  • Heterocyclic GPCR Agonists
    Publication number: 20110178054
    Abstract: Compounds of formula (I): or pharmaceutically acceptable salts thereof, are GPCR (GPR119) agonists and are useful as for the treatment of diabetes and obesity.
    Type: Application
    Filed: July 10, 2009
    Publication date: July 21, 2011
    Applicant: Prosidion Limited
    Inventors: Lisa Sarah Bertram, Matthew Colin Thor Fyfe, William Gattrell, Revathy P. Jeevaratnam, John Keily, Martin James Procter
  • PIPERIDINE GPCR AGONISTS
    Publication number: 20100105732
    Abstract: Compounds of formula (I): or pharmaceutically acceptable salts thereof, are GPCR agonists and are useful as for the treatment of obesity and diabetes.
    Type: Application
    Filed: January 4, 2008
    Publication date: April 29, 2010
    Inventors: Matthew Colin Thor Fyfe, Revathy Perpetua Jeevaratnam, John Keily, Simon Andrew Swain, Lisa Sarah Bertram
  • Piperidine GPCR Agonists
    Publication number: 20100048632
    Abstract: Compounds of formula (I): or pharmaceutically acceptable salts thereof, are GPCR agonists and are useful as for the treatment of obesity and diabetes.
    Type: Application
    Filed: January 4, 2008
    Publication date: February 25, 2010
    Inventors: Matthew Colin Thor Fyfe, John Keily, Simon Andrew Swain
  • PIPERIDINE GPCR AGONISTS
    Publication number: 20100048625
    Abstract: Compounds of formula (I): or pharmaceutically acceptable salts thereof, are GPCR agonists and are useful as for the treatment of obesity and diabetes.
    Type: Application
    Filed: January 4, 2008
    Publication date: February 25, 2010
    Inventors: Matthew Colin Thor Fyfe, Revathy Perpetua Jeevaratnam, John Keily, Simon Andrew Swain
  • Piperidine GPCR Agonists
    Publication number: 20100048631
    Abstract: Compounds of formula (I): or pharmaceutically acceptable salts thereof, are GPCR agonists and are useful as for the treatment of obesity and diabetes.
    Type: Application
    Filed: January 4, 2008
    Publication date: February 25, 2010
    Inventors: Matthew Colin Thor Fyfe, John Keily, Martin Procter, David French Stonehouse, Simon Andrew Swain
  • PIPERIDINE GPCR AGONISTS
    Publication number: 20100022591
    Abstract: Compounds of formula (I): or pharmaceutically acceptable salts thereof, are GPCR agonists and are useful as for the treatment of obesity and diabetes.
    Type: Application
    Filed: January 4, 2008
    Publication date: January 28, 2010
    Inventors: Lisa Sarah Bertram, Matthew Colin Thor Fyfe, Revathy Perpetua Jeevaratnam, John Keily, Simon Andrew Swain
  • GPCR Agonists
    Publication number: 20090325924
    Abstract: Compounds of formula (I): or pharmaceutically acceptable salts thereof, are GPCR agonists and are useful as for the treatment of obesity and diabetes.
    Type: Application
    Filed: June 29, 2006
    Publication date: December 31, 2009
    Inventors: Stuart Edward, Graham John Dawson, Matthew Colin Thor Fyfe Oxford, Lisa Sarah Bertram, William Gattrell, Revathy Perpetua Jeevaratnam, John Keily, Neela Sumit Mistry, Martin James Procter, Chrystelle Marie Rasamison, Philip John Rushworth, Colin Peter Sambrook-Smith, David French Stonehouse
  • Aryl Urea Derivatives for Treating Obesity
    Publication number: 20080261952
    Abstract: A method of treating a condition associated with the CB-1 receptor, in particular obesity, by administering an effective amount of an aryl urea CB-1 receptor modulating compound to a subject in need of such treatment.
    Type: Application
    Filed: August 16, 2005
    Publication date: October 23, 2008
    Inventors: Jason Bloxham, Matthew Colin Thor Fyfe, James Horswill, Revathy Perpetua Jeevaratnam, John Keily, Martin James Procter, Karen Lesley Schofield, Salam Shaaban, Andrew Simon Swain, Phillppe Wong-Kai-In